查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1810835

2025年全球心房顫動設備市場報告

Atrial Fibrillation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年心房顫動設備市場將快速成長，到2029年將達到132.8億美元，年複合成長率（CAGR）為11.5%。預測期內的成長歸因於醫療保健支出的增加、多專科醫院的增加、先進治療方案的日益普及、監管機構對設備核准的支持力度的加大，以及對微創外科手術的需求不斷成長。預測期內的主要趨勢包括技術進步、遠端監控設備的改進、人工智慧在診斷過程中的整合、微創消融系統的創新以及測繪和成像技術的改進。

心血管疾病負擔的加重預計將在未來幾年推動心房顫動設備市場的成長。心血管疾病包括影響心臟和血管的疾病，如心臟病發作、中風和高血壓。這些疾病的盛行率不斷上升，主要是由於全球肥胖症和糖尿病發病率的上升，以及久坐不動的生活方式和不健康的飲食習慣。心房顫動 (AFib) 裝置對於管理心血管疾病至關重要，它透過檢測、監測和治療心律不整來管理心血管疾病，而心律不整通常與潛在的心臟疾病有關。例如，美國公共衛生組織美國心臟協會於 2024 年 6 月報告稱，高血壓的盛行率預計將從 51.2% 上升至 61.0%，到 2050 年，被診斷患有心血管疾病的人數將從 2020 年的 1.28 億增加到 1.84 億以上。因此，心血管疾病盛行率的上升正在促進心房顫動設備市場的擴張。

心房顫動設備市場的主要參與者正專注於技術進步，例如以患者為中心的臨床決策支援工具，以提高診斷準確性、客製化治療策略並改善患者預後。這些工具是數位化系統，旨在透過分析患者個別數據並幫助醫療服務提供者做出更個人化的照護決策來協助他們。例如，2023年8月，美國醫療科技公司GE Healthcare Technologies推出了CardioVisio for Atrial Fibrillation，這是一款數位化臨床決策支援工具，旨在簡化臨床醫生的工作流程，並協助對心房顫動患者進行針對性治療。該工具有助於可視化心房顫動的進展，並整合先前診斷、治療、藥物和相關疾病。它還根據既定指南提供治療方法建議，減少診斷錯誤的可能性，並促進更有效率的臨床決策。 CardioVisio將分散的患者資料整合成易於存取的格式，幫助醫療專業人員更有效地管理心房顫動。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心房顫動設備：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球心房顫動設備市場：成長率分析
  • 全球心房顫動設備市場表現：規模與成長，2019-2024
  • 全球心房顫動設備市場預測：規模與成長，2024-2029 年，2034 年
  • 全球心房顫動設備：總目標市場（TAM）

第6章市場區隔

  • 全球心房顫動設備市場：按設備類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式裝置
  • 外部設備
  • 導管式裝置
  • 全球心房顫動設備市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 電生理消融導管
  • 心臟監測儀或植入式循環記錄儀
  • 電氣生理學診斷導管
  • 測繪和記錄系統
  • 存取裝置
  • 心內超音波心臟檢查
  • 左心耳封堵器
  • 其他產品
  • 全球心房顫動設備市場：依技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 射頻
  • 冷凍療法
  • 超音波
  • 其他技術
  • 全球心房顫動設備市場：按分銷管道、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 直銷
  • 經銷商
  • 網上銷售
  • 全球心房顫動設備市場：依最終用途、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 心臟中心
  • 門診手術中心
  • 其他最終用戶
  • 全球心房顫動設備市場：依植入式裝置類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式心臟整流去顫器
  • 心律調節器
  • 可插入式心臟監視器
  • 全球心房顫動設備市場：按外部設備細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 體外去心房顫動
  • 心電圖監測
  • 行動心電遙測設備
  • 心電圖監測儀
  • 全球心房顫動設備市場：按導管設備細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 射頻消融術導管
  • 冷凍消融導管
  • 雷射消熔導管
  • 地圖和導航系統
  • 經心房中隔通路裝置

第7章 區域和國家分析

  • 全球心房顫動設備市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球心房顫動設備市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心房顫動設備市場：競爭格局
  • 心房顫動設備市場：公司簡介
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Shanghai MicroPort EP MedTech Co. Ltd.
  • Japan Lifeline Co. Ltd.
  • Microlife Corporation
  • AliveCor Inc.
  • CardioFocus Inc.
  • Imricor Medical Systems Inc.
  • Kardium Inc.
  • Stereotaxis Inc.
  • Volta Medical
  • Synaptic Medical Corporation
  • Osypka AG
  • CathRx Ltd.
  • BIOTRONIK SE & Co. KG
  • EP Solutions SA
  • CardiacSense Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年心房顫動設備市場：提供新機會的國家
  • 2029 年心房顫動設備市場：細分市場帶來新機會
  • 2029 年心房顫動設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r36933

Atrial fibrillation (AFib) devices are medical technologies developed to detect, monitor, or treat atrial fibrillation, a prevalent heart rhythm disorder characterized by irregular beating of the heart's upper chambers. These devices include implantable cardiac monitors, pacemakers, defibrillators, catheter ablation systems, and wearable electrocardiogram (ECG) monitors. The primary objective of AFib devices is to restore normal heart rhythm, minimize stroke risk, and enhance quality of life.

The main types of atrial fibrillation devices include implantable devices, external devices, and catheter-based devices. Implantable devices refer to tools such as pacemakers, implantable cardioverter defibrillators (ICDs), and implantable loop recorders, which are surgically placed within the body to monitor, regulate, or correct heart rhythm by delivering electrical impulses or continuously recording cardiac activity. These devices are used across various applications, including electrophysiology ablation catheters, cardiac monitors or implantable loop recorders, electrophysiology diagnostic catheters, mapping and recording systems, access devices, intracardiac echocardiography, left atrial appendage closure devices, and other related tools. They operate using technologies such as radiofrequency, cryotherapy, ultrasound, and other advanced methods. Distribution channels include direct sales, distributors, and online platforms, serving end users such as hospitals, cardiac centers, ambulatory surgical centers, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The atrial fibrillation devices market research report is one of a series of new reports from The Business Research Company that provides atrial fibrillation devices market statistics, including atrial fibrillation devices industry global market size, regional shares, competitors with a atrial fibrillation devices market share, detailed atrial fibrillation devices market segments, market trends and opportunities, and any further data you may need to thrive in the atrial fibrillation devices industry. This atrial fibrillation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The atrial fibrillation devices market size has grown rapidly in recent years. It will grow from $7.69 billion in 2024 to $8.60 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period can be attributed to an increase in the aging population, rising demand for minimally invasive cardiac procedures, expansion of government initiatives, and greater availability of telecardiology services.

The atrial fibrillation devices market size is expected to see rapid growth in the next few years. It will grow to $13.28 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth during the forecast period can be attributed to rising healthcare expenditure, an increasing number of multi-specialty hospitals, greater adoption of advanced treatment options, enhanced regulatory support for device approvals, and growing demand for minimally invasive surgical procedures. Key trends anticipated in the forecast period include technological advancements, progress in remote monitoring devices, integration of artificial intelligence in diagnostic processes, innovations in minimally invasive ablation systems, and improvements in mapping and imaging technologies.

The increasing burden of cardiovascular diseases is expected to drive the growth of the atrial fibrillation device market in the coming years. Cardiovascular diseases encompass conditions that affect the heart and blood vessels, such as heart attacks, strokes, and hypertension. The growing prevalence of these conditions is largely attributed to rising global rates of obesity and diabetes, combined with sedentary lifestyles and unhealthy eating habits. Atrial fibrillation (AFib) devices are essential for managing cardiovascular diseases by detecting, monitoring, and treating irregular heart rhythms, which are frequently linked to underlying heart problems. For example, in June 2024, the American Heart Association, a US-based public health organization, reported that as the prevalence of high blood pressure is projected to increase from 51.2% to 61.0%, the number of individuals diagnosed with cardiovascular diseases is expected to grow from 128 million in 2020 to over 184 million by 2050. Thus, the rising incidence of cardiovascular diseases is contributing to the expansion of the atrial fibrillation device market.

Key players in the atrial fibrillation devices market are focusing on technological advancements, such as patient-centric clinical decision support tools, to improve diagnostic accuracy, customize treatment strategies, and enhance patient outcomes. These tools are digital systems designed to assist healthcare providers by analyzing individual patient data to inform more personalized care decisions. For instance, in August 2023, GE HealthCare Technologies Inc., a US-based medical technology company, introduced CardioVisio for Atrial Fibrillation, a digital clinical decision support tool created to streamline clinician workflows and support targeted care for AFib patients. The tool helps visualize AFib progression, incorporating previous diagnoses, treatments, medications, and related conditions. It also provides therapy recommendations based on established guidelines, reducing the likelihood of diagnostic errors and facilitating more efficient clinical decision-making. CardioVisio consolidates scattered patient data into an accessible format, helping medical professionals manage atrial fibrillation more effectively and efficiently.

In November 2023, Johnson & Johnson MedTech, a US-based medical technology firm, acquired Laminar Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson MedTech's position in the atrial fibrillation device sector and broaden its range of solutions focused on stroke prevention and cardiac care. Laminar Inc. is a US-based company specializing in the development of innovative devices for left atrial appendage elimination, which are used to prevent strokes in patients with atrial fibrillation.

Major players in the atrial fibrillation devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips N.V., Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co. Ltd., Japan Lifeline Co. Ltd., Microlife Corporation, AliveCor Inc., CardioFocus Inc., Imricor Medical Systems Inc., Kardium Inc., Stereotaxis Inc., Volta Medical, Synaptic Medical Corporation, Osypka AG, CathRx Ltd., BIOTRONIK SE & Co. KG, EP Solutions SA, CardiacSense Ltd.

North America was the largest region in the atrial fibrillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in atrial fibrillation devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the atrial fibrillation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atrial fibrillation devices market consists of revenues earned by entities providing services such as diagnostic services, therapeutic services, and patient monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial fibrillation devices market also includes sales of cryoablation catheters, laser ablation systems, and hybrid ablation systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atrial Fibrillation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atrial fibrillation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atrial fibrillation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The atrial fibrillation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Implantable Devices; External Devices; Catheter-Based Devices
  • 2) By Product: Electrophysiology Ablation Catheters; Cardiac Monitors Or Implantable Loop Recorder; Electrophysiology Diagnostic Catheters; Mapping And Recording Systems; Access Devices; Intracardiac Echocardiography; Left Atrial Appendage Closure Devices; Other Products
  • 3) By Technology: Radiofrequency; Cryotherapy; Ultrasound; Other Technologies
  • 4) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 5) By End-Use: Hospitals; Cardiac Centers; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Implantable Devices: Implantable Cardioverter Defibrillators; Pacemakers; Insertable Cardiac Monitors
  • 2) By External Devices: External Defibrillators; Holter Monitors; Mobile Cardiac Telemetry Devices; Electrocardiogram Monitors
  • 3) By Catheter-Based Devices: Radiofrequency Ablation Catheters; Cryoablation Catheters; Laser Ablation Catheters; Mapping and Navigation Systems; Transseptal Access Devices
  • Companies Mentioned: Johnson & Johnson Services Inc.; Abbott Laboratories; Medtronic Public Limited Company; Koninklijke Philips N.V.; Boston Scientific Corporation; Shanghai MicroPort EP MedTech Co. Ltd.; Japan Lifeline Co. Ltd.; Microlife Corporation; AliveCor Inc.; CardioFocus Inc.; Imricor Medical Systems Inc.; Kardium Inc.; Stereotaxis Inc.; Volta Medical; Synaptic Medical Corporation; Osypka AG; CathRx Ltd.; BIOTRONIK SE & Co. KG; EP Solutions SA; CardiacSense Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Atrial Fibrillation Devices Market Characteristics

3. Atrial Fibrillation Devices Market Trends And Strategies

4. Atrial Fibrillation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Atrial Fibrillation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Atrial Fibrillation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Atrial Fibrillation Devices Market Growth Rate Analysis
  • 5.4. Global Atrial Fibrillation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Atrial Fibrillation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Atrial Fibrillation Devices Total Addressable Market (TAM)

6. Atrial Fibrillation Devices Market Segmentation

  • 6.1. Global Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Devices
  • External Devices
  • Catheter-Based Devices
  • 6.2. Global Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrophysiology Ablation Catheters
  • Cardiac Monitors Or Implantable Loop Recorder
  • Electrophysiology Diagnostic Catheters
  • Mapping And Recording Systems
  • Access Devices
  • Intracardiac Echocardiography
  • Left Atrial Appendage Closure Devices
  • Other Products
  • 6.3. Global Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency
  • Cryotherapy
  • Ultrasound
  • Other Technologies
  • 6.4. Global Atrial Fibrillation Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Distributors
  • Online Sales
  • 6.5. Global Atrial Fibrillation Devices Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cardiac Centers
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.6. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Implantable Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Cardioverter Defibrillators
  • Pacemakers
  • Insertable Cardiac Monitors
  • 6.7. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of External Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • External Defibrillators
  • Holter Monitors
  • Mobile Cardiac Telemetry Devices
  • Electrocardiogram Monitors
  • 6.8. Global Atrial Fibrillation Devices Market, Sub-Segmentation Of Catheter-Based Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Catheters
  • Cryoablation Catheters
  • Laser Ablation Catheters
  • Mapping And Navigation Systems
  • Transseptal Access Devices

7. Atrial Fibrillation Devices Market Regional And Country Analysis

  • 7.1. Global Atrial Fibrillation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Atrial Fibrillation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atrial Fibrillation Devices Market

  • 8.1. Asia-Pacific Atrial Fibrillation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atrial Fibrillation Devices Market

  • 9.1. China Atrial Fibrillation Devices Market Overview
  • 9.2. China Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atrial Fibrillation Devices Market

  • 10.1. India Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atrial Fibrillation Devices Market

  • 11.1. Japan Atrial Fibrillation Devices Market Overview
  • 11.2. Japan Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atrial Fibrillation Devices Market

  • 12.1. Australia Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atrial Fibrillation Devices Market

  • 13.1. Indonesia Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atrial Fibrillation Devices Market

  • 14.1. South Korea Atrial Fibrillation Devices Market Overview
  • 14.2. South Korea Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atrial Fibrillation Devices Market

  • 15.1. Western Europe Atrial Fibrillation Devices Market Overview
  • 15.2. Western Europe Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atrial Fibrillation Devices Market

  • 16.1. UK Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atrial Fibrillation Devices Market

  • 17.1. Germany Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atrial Fibrillation Devices Market

  • 18.1. France Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atrial Fibrillation Devices Market

  • 19.1. Italy Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atrial Fibrillation Devices Market

  • 20.1. Spain Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atrial Fibrillation Devices Market

  • 21.1. Eastern Europe Atrial Fibrillation Devices Market Overview
  • 21.2. Eastern Europe Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atrial Fibrillation Devices Market

  • 22.1. Russia Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atrial Fibrillation Devices Market

  • 23.1. North America Atrial Fibrillation Devices Market Overview
  • 23.2. North America Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atrial Fibrillation Devices Market

  • 24.1. USA Atrial Fibrillation Devices Market Overview
  • 24.2. USA Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atrial Fibrillation Devices Market

  • 25.1. Canada Atrial Fibrillation Devices Market Overview
  • 25.2. Canada Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atrial Fibrillation Devices Market

  • 26.1. South America Atrial Fibrillation Devices Market Overview
  • 26.2. South America Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atrial Fibrillation Devices Market

  • 27.1. Brazil Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atrial Fibrillation Devices Market

  • 28.1. Middle East Atrial Fibrillation Devices Market Overview
  • 28.2. Middle East Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atrial Fibrillation Devices Market

  • 29.1. Africa Atrial Fibrillation Devices Market Overview
  • 29.2. Africa Atrial Fibrillation Devices Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Atrial Fibrillation Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Atrial Fibrillation Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atrial Fibrillation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Atrial Fibrillation Devices Market Competitive Landscape
  • 30.2. Atrial Fibrillation Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Atrial Fibrillation Devices Market Other Major And Innovative Companies

  • 31.1. Shanghai MicroPort EP MedTech Co. Ltd.
  • 31.2. Japan Lifeline Co. Ltd.
  • 31.3. Microlife Corporation
  • 31.4. AliveCor Inc.
  • 31.5. CardioFocus Inc.
  • 31.6. Imricor Medical Systems Inc.
  • 31.7. Kardium Inc.
  • 31.8. Stereotaxis Inc.
  • 31.9. Volta Medical
  • 31.10. Synaptic Medical Corporation
  • 31.11. Osypka AG
  • 31.12. CathRx Ltd.
  • 31.13. BIOTRONIK SE & Co. KG
  • 31.14. EP Solutions SA
  • 31.15. CardiacSense Ltd.

32. Global Atrial Fibrillation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atrial Fibrillation Devices Market

34. Recent Developments In The Atrial Fibrillation Devices Market

35. Atrial Fibrillation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Atrial Fibrillation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Atrial Fibrillation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Atrial Fibrillation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer